Literature DB >> 24553825

[Sural nerve biopsy for unclear polyneuropathy. Against].

P Young1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24553825     DOI： 10.1007/s00115-014-4003-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.

Authors:  P Y K Van den Bergh; R D M Hadden; P Bouche; D R Cornblath; A Hahn; I Illa; C L Koski; J-M Léger; E Nobile-Orazio; J Pollard; C Sommer; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2010-03       Impact factor: 6.089

2.  Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population.

Authors:  Yusuf A Rajabally; Benjamin S Simpson; Sushil Beri; John Bankart; Jayaprakash A Gosalakkal
Journal:  Muscle Nerve       Date:  2009-04       Impact factor: 3.217

3.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

4.  Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population.

Authors:  Burkhard Gess; Anja Schirmacher; Matthias Boentert; Peter Young
Journal:  Neuromuscul Disord       Date:  2013-06-03       Impact factor: 4.296

5.  Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy.

Authors:  Albert Ruth; Frank J Schulmeyer; Manuela Roesch; Chris Woertgen; Alexander Brawanski
Journal:  Clin Neurol Neurosurg       Date:  2005-04       Impact factor: 1.876

Review 6.  Clinical implications of genetic advances in Charcot-Marie-Tooth disease.

Authors:  Alexander M Rossor; James M Polke; Henry Houlden; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2013-09-10       Impact factor: 42.937
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.